Amidst stalled HIV prevention, WHO supports new long-acting prevention drug cabotegravir

The UN health agency on Thursday recommended the use of a new long-acting “safe and highly effective” prevention option for people at “substantial risk” of HIV infection, known as cabotegravir (CAB-LA).
Source: UN News Centre - Health, Poverty, Food Security - Category: International Medicine & Public Health Source Type: news